PHASE III MEDICAL, INC. DEF 14A

Company

LISATA THERAPEUTICS, INC.

Filed

August 1, 2006

Period of Report

August 29, 2006

Accession Number

0001157523-06-007699

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →